Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Pathologie-Biologie|September 1, 1978
[Comparison of serum levels of beta2-microglobulin and carcino-embryonic antigen in the follow-up of lung cancer (author's transl)]C Ardiet, R Gonthier, P Pasquet, et al.Bulletin Du Cancer|January 1, 1988
[Pharmacokinetics of high-dose melphalan (200 mg/m2) in a case of total renal insufficiency]B Tranchand, P Biron, A Mercatello, et al.Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 casesC Ardiet, B Tranchand, P Biron, et al.Bulletin Du Cancer|July 1, 1995
[Cytotoxic chemotherapy in elderly patients: present and future]G Freyer, P Maire, C Ardiet, et al.Annales D'Endocrinologie|January 1, 1983
[Effect of estrogens on the value of serum thyroglobulin]B Estour, H Bornet, M H Bernard, et al.Bulletin Du Cancer|January 1, 1994
[Effect of carboplatin on the pharmacokinetics of melphalan administered intravenously]B Tranchand, C Ardiet, E Bouffet, et al.Investigational New Drugs|January 1, 1995
Phase I and pharmacokinetic study of KW-2149 given by 24 hours continuous infusionL Dirix, G Catimel, R Verdonk, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose melphalan dosage adjustment: possibility of using a test-doseB Tranchand, Y D Ploin, M P Minuit, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinomaD Y Ploin, B Tranchand, J P Guastalla, et al.Pageof 3